Endocrinology, Vol 135, 782-789, Copyright © 1994 by Endocrine Society

ARTICLES

Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells

A Ikegami, S Inoue, T Hosoi, M Kaneki, Y Mizuno, Y Akedo, Y Ouchi and H Orimo
Department of Geriatrics, Faculty of Medicine, University of Tokyo, Japan.

Dual fluoroimmunohistochemical staining of estrogen receptor (ER) and bromodeoxyuridine was performed in a human osteoblastic osteosarcoma cell line, HOS TE85 cells. ER immunoreactivity was observed preferentially in the nuclei of the cells that were bromodeoxyuridine positive. ER expression at various phases of the cell cycle was investigated in HOS TE85 cells, which were synchronized at the G1/S phase boundary by intermittent exposure to thymidine and hydroxyurea. ER immunoreactivity became detectable in the S phase, decreased in the G2/M and G1 phases, and then reappeared in the S phase of the next cell cycle. Western blot analysis also showed that ER protein exists in these cells and increases in the S phase. Moreover, Northern blot analysis demonstrated that the expression of ER messenger RNA increases in the early S phase, gradually decreases during the progress of the cell cycle, and increases again in the S phase of the subsequent cell cycle. Interestingly, 17 beta-estradiol (10(-8) M) increased cell number and [3H]thymidine incorporation into DNA in the synchronized HOS TE85 cells, whereas this effect was not observed in the nonsynchronized HOS TE85 cells. The present studies suggest that the cell cycle- dependent regulation may contribute to the heterogeneity of ER expression in osteoblastic cells.

This article has been cited by other articles:

				H. Amlal, S. Faroqui, A. Balasubramaniam, and S. Sheriff Estrogen Up-regulates Neuropeptide Y Y1 Receptor Expression in a Human Breast Cancer Cell Line. Cancer Res., April 1, 2006; 66(7): 3706 - 3714. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				T. Maruyama, Y. Sachi, K. Furuke, Y. Kitaoka, H. Kanzaki, Y. Yoshimura, and J. Yodoi Induction of Thioredoxin, a Redox-Active Protein, by Ovarian Steroid Hormones during Growth and Differentiation of Endometrial Stromal Cells in Vitro Endocrinology, January 1, 1999; 140(1): 365 - 372. [Abstract] [Full Text]

				G. Flouriot, C. Griffin, M. Kenealy, V. Sonntag-Buck, and F. Gannon Differentially Expressed Messenger RNA Isoforms of the Human Estrogen Receptor-{alpha} Gene Are Generated by Alternative Splicing and Promoter Usage Mol. Endocrinol., December 1, 1998; 12(12): 1939 - 1954. [Abstract] [Full Text]

				S. S. Chaidarun and J. M. Alexander A Tumor-Specific Truncated Estrogen Receptor Splice Variant Enhances Estrogen-Stimulated Gene Expression Mol. Endocrinol., September 1, 1998; 12(9): 1355 - 1366. [Abstract] [Full Text]

				P. V. N. Bodine, R. A. Henderson, J. Green, M. Aronow, T. Owen, G. S. Stein, J. B. Lian, and B. S. Komm Estrogen Receptor-{alpha} Is Developmentally Regulated during Osteoblast Differentiation and Contributes to Selective Responsiveness of Gene Expression Endocrinology, April 1, 1998; 139(4): 2048 - 2057. [Abstract] [Full Text] [PDF]

				F. McL. Collier, W. H. Huang, W. R. Holloway, J. M. Hodge, M. T. Gillespie, L. L. Daniels, M. H. Zheng, and G. C. Nicholson Osteoclasts from Human Giant Cell Tumors of Bone Lack Estrogen Receptors Endocrinology, March 1, 1998; 139(3): 1258 - 1267. [Abstract] [Full Text] [PDF]

				Y. Matsubara, M. Murata, K. Kawano, T. Zama, N. Aoki, H. Yoshino, G. Watanabe, K. Ishikawa, and Y. Ikeda Genotype Distribution of Estrogen Receptor Polymorphisms in Men and Postmenopausal Women From Healthy and Coronary Populations and Its Relation to Serum Lipid Levels Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3006 - 3012. [Abstract] [Full Text]